Clinical Research at Norton Children’s

Providing children with quality health care requires more than office visits and hospital stays. The specialists with Norton Children’s, in partnership with the University of Louisville, are broadening knowledge of pediatric diseases, discovering new therapies and ultimately improving care.

Our pediatric specialists are pursuing clinical and translational research that brings new treatments and improved therapies to children.

See our endowed chairs.

Norton Children’s Research Institute, affiliated with the UofL School of Medicine, is made up of dedicated and experienced clinical researchers, coordinators, nurses, pharmacists and other staff. Our team conducts patient-oriented research to improve health care and the safety of medicines and devices in children from birth to adulthood, and includes all races and genders.

Our pediatric specialists conduct clinical pharmacology research and device research studies, with locations at Norton Children’s Hospital and the Novak Center for Children’s Health. These locations allow inpatients and outpatients to participate in trials, as well as provide education and training in research initiatives for the medical providers of tomorrow. Hundreds of children each year participate in studies right here at home.

Pediatric research is conducted in a multitude of areas. If you are interested in research trials available, talk to your child’s physician about options.

Inpatient clinical trial studies conducted at Norton Children’s Hospital include:

  • Antibiotic studies
  • Cardiology studies
  • Critical care studies
  • Infectious diseases studies
  • Kidney studies
  • Neonatal intensive care studies

Outpatient clinical trial studies conducted at the Novak Center for Children’s Health include the following conditions:

  • Autism
  • Cystic fibrosis
  • Chronic kidney disease
  • Diabetes
  • Epilepsy
  • Genetic conditions
  • Hematologic conditions
  • Infectious diseases
  • Juvenile idiopathic arthritis
  • Multiple sclerosis

See all open research trials at Norton Children’s Research Institute.

Did You Know? 

  • Of prescribed medicines given to children, 70% to 80% are not approved for use in children by the U.S. Food and Drug Administration (FDA). Most have been tested only in adults.
  • Norton Children’s Research Institute works with drug companies and federal agencies to make sure medications and medical treatments are safe for your child.
  • The research team works closely with your child’s physician throughout the study to ensure that your child receives the best and safest care possible.
  • Some of our studies already have made positive changes in the way that we prescribe medications and provide care to children.
  • We have a research nurse on call 24 hours a day, seven days a week. In clinical trials, patient safety is always our first priority.
  • It is often thought that clinical trials are mainly for people who have no other option. In fact, clinical trials can be an additional option to help you and your child through their medical care.

 

Research

Support Research at Norton Children’s

Research at Norton Children’s is made possible thanks to the generosity of donors who wish to support important advances in pediatric health.
Donate today


Or call (502) 629-8060

COVID-19 puts pediatric patients with bleeding disorders at higher risk

Some pediatric patients with bleeding disorders may have a higher risk of severe illness from COVID-19, especially if they have serious underlying medical conditions such as heart disease, diabetes, obesity or asthma. Although most bleeding […]

Read Full Story

Diet rich in antioxidants can help prevent infection during pediatric leukemia treatment

A healthy diet that includes foods — not dietary supplements — rich in antioxidants can help kids undergoing treatment for acute lymphoblastic leukemia (ALL) reduce the risk of infection and inflammation in the digestive tract, […]

Read Full Story

Normal bruises or leukemia bruising? How to spot the difference

Leukemia bruising occurs more easily and frequently than typical bruising, may show up in odd places, tends to take longer to clear up and can be part of a number of symptoms seen on a […]

Read Full Story

Norton Children’s Cancer Institute offers clinical trials for kids with AML

It’s the news no parent wants to hear: acute myeloid leukemia (AML). This cancer of the bone marrow — the spongy tissue inside bones where blood cells are made — is rare but dangerous, affecting […]

Read Full Story

New drug treats hemophilia A in children

Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, cares for children with hemophilia, blood cancers and many other diseases. Emicizumab is a new drug now being used for children with moderate to […]

Read Full Story
Related Stories

COVID-19 puts pediatric patients with bleeding disorders at higher risk

Some pediatric patients with bleeding disorders may have a higher risk of severe illness from COVID-19, especially if they have serious underlying medical conditions such as heart disease, diabetes, obesity or asthma. Although most bleeding […]

Read Full Story

Diet rich in antioxidants can help prevent infection during pediatric leukemia treatment

A healthy diet that includes foods — not dietary supplements — rich in antioxidants can help kids undergoing treatment for acute lymphoblastic leukemia (ALL) reduce the risk of infection and inflammation in the digestive tract, […]

Read Full Story

Normal bruises or leukemia bruising? How to spot the difference

Leukemia bruising occurs more easily and frequently than typical bruising, may show up in odd places, tends to take longer to clear up and can be part of a number of symptoms seen on a […]

Read Full Story

Norton Children’s Cancer Institute offers clinical trials for kids with AML

It’s the news no parent wants to hear: acute myeloid leukemia (AML). This cancer of the bone marrow — the spongy tissue inside bones where blood cells are made — is rare but dangerous, affecting […]

Read Full Story

New drug treats hemophilia A in children

Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, cares for children with hemophilia, blood cancers and many other diseases. Emicizumab is a new drug now being used for children with moderate to […]

Read Full Story

Search our entire site.